首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Molecular therapy-methods & clinical development

缩写:

ISSN:N/A

e-ISSN:2329-0501

IF/分区:4.7/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引1806
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Seunga Choo,Alvin H Tong,Emily Fields et al. Seunga Choo et al.
Autologous transplantation of ex vivo gene-modified/corrected hematopoietic stem cells (HSCs) offers a definitive therapeutic approach to restore hematopoiesis in Fanconi anemia (FA) patients. However, this approach not only requires ex viv...
Robert Duba-Kiss,David R Hampson Robert Duba-Kiss
A barrier in the development of adeno-associated virus (AAV) gene therapy is the immunogenicity of the AAV particles, and in some cases, the expressed transgene. The immunogenic risk is heightened when exogenous proteins, such as prokaryoti...
I J J Muffels,R Budhraja,S Radenkovic et al. I J J Muffels et al.
The ability of adeno-associated viruses (AAVs) to transduce host cells relies on interactions with glycan moieties on the cellular surface. Consequently, disrupted protein glycosylation, which is seen in a range of neurodevelopmental and ne...
Mark A Currier,Allen Reha,Brian Hutzen et al. Mark A Currier et al.
We previously described the use of recombinant adeno-associated virus (AAV) gene therapy to achieve off-the-shelf, long-term in vivo T cell engagement for CD19+ B cell malignancies following a single dose by expressing a transgene encoding ...
S Sohn,S Reid,M Bowen et al. S Sohn et al.
The aberrant expression of the toxic transcription factor DUX4 in skeletal muscle is a hallmark of facioscapulohumeral muscular dystrophy. Effective therapeutic strategies will likely require the inhibition of DUX4, with adeno-associated vi...
Ting Zhang,Rongqun Zhai,Mengli Liu et al. Ting Zhang et al.
Genetic hearing loss, caused by mutations in critical auditory genes, has seen promising advances through gene therapy, yet the temporal dynamics of early-stage auditory functional recovery and therapeutic transgene expression patterns foll...
Rui Hou,Zejun Zhang,Huan Li et al. Rui Hou et al.
Precise assessment of the cytotoxic activity of engineered immune cell therapeutics, such as chimeric antigen receptor-engineered T (CAR-T) cells, is essential for their development and quality control. However, luciferase (Luc)-based viabi...
Aishwarya Shevade,John S Reeves,Hanne Bak et al. Aishwarya Shevade et al.
Recombinant, non-replicative adeno-associated virus (AAV) containing a therapeutic gene of interest (GOI) is widely used as a vector for gene therapy. One way to manufacture AAV is through triple-transfection of HEK293 cells, with plasmids ...
George Pamenter,Danyal H Rahim,Ciaran Lamont et al. George Pamenter et al.
The growing demand for lentiviral vectors (LVs) in cell and gene therapies has highlighted significant challenges in large-scale LV production, particularly low product recovery. Anion-exchange chromatography (AIEX) is widely used for LV ca...
Miyu Nakayama,Yuu Moriya,Hikaru Ueno et al. Miyu Nakayama et al.
Induced pluripotent stem cells (iPSCs) have substantial transformative potential in regenerative medicine, enabling tissue repair and restoration. However, their clinical application is limited by tumorigenic risks owing to their pluripoten...